- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Myelofibrosis (MF)
- Meeting Date: May 2025
- Public Summary Document (PSD) May 2025 PBAC Meeting - (PDF)
- Public Summary Document (PSD) May 2025 PBAC Meeting - (Word)
Fedratinib – May 2025
Fedratinib: Capsule 100 mg; Inrebic®
Last updated
9 May 2025